Reply to F. de Marinis et al
Journal
Journal of Clinical Oncology
Journal Volume
32
Journal Issue
8
Date Issued
2014
Author(s)
Sequist L.V.
SDGs
Other Subjects
afatinib; epidermal growth factor receptor; loperamide; afatinib; antineoplastic agent; epidermal growth factor receptor; quinazoline derivative; cancer chemotherapy; clinical trial (topic); diarrhea; diet; drug dose reduction; drug safety; gene mutation; human; letter; priority journal; progression free survival; quality of life; treatment duration; adenocarcinoma; female; genetics; lung adenocarcinoma; lung tumor; male; note; Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Lung Neoplasms; Male; Quinazolines; Receptor, Epidermal Growth Factor
Publisher
American Society of Clinical Oncology
Type
letter